U.S., May 2 -- ClinicalTrials.gov registry received information related to the study (NCT06954025) titled 'High-Intensity Inpatient MDMA-Assisted Psychotherapy for PTSD' on April 24.
Brief Summary: This study will evaluate the feasibility, safety and efficacy of high-intensity inpatient MDMA-assisted psychotherapy for treatment-refractory posttraumatic stress disorder.
Study Start Date: May, 2025
Study Type: INTERVENTIONAL
Condition:
Posttraumatic Stress Disorder (PTSD)
Intervention:
DRUG: High-intensity inpatient MDMA-assisted psychotherapy
Drug: 3,4-methylenedioxymethamphetamine (MDMA) Session 1: 80 mg MDMA HCl followed by a supplemental dose of 40 mg Session 2: 120 mg MDMA HCl followed by a supplemental dose of 60 mg
Psychothera...